| Literature DB >> 11012169 |
L Cao1, P Kulmburg, H Veelken, A Mackensen, B Mézes, A Lindemann, R Mertelsmann, F M Rosenthal.
Abstract
New strategies based on gene transfer technology are employed in cancer therapy. Cytokines are polypeptides involved in immunity and inflammation, and essentially control the magnitude of the immune response. Genetically modified tumor cells releasing various cytokines have been shown to enhance tumor immunogenicity and to induce the regression of preexisting tumors. In some instances, immunological memory has been generated to resist the subsequent challenge with unmodified, parental tumor cells. Cytokine gene transfer into antitumor effector cells, as well as antigen presenting cells, is also being investigated to augment antitumor immune responses.Entities:
Mesh:
Substances:
Year: 1998 PMID: 11012169 DOI: 10.1002/stem.5530160831
Source DB: PubMed Journal: Stem Cells ISSN: 1066-5099 Impact factor: 6.277